DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Arcutis Biotherapeutics Reports Inclusion Of Children In On-Going Phase 3 Trials Evaluating ARQ-151 As Potential Once Daily Topical Treatment For Plaque Psoriasis

Benzinga · 03/16/2020 12:48